Study
Increased Mortality Risk with Hypnotics and Anxiolytics in Older Adults
Older adults using hypnotics or anxiolytics have a 43% higher risk of mortality compared to non-users.
Summary
In plain language
A recent study found that older adults who use medications like hypnotics and anxiolytics face a higher risk of mortality compared to those who don't. Researchers analyzed data from over 2 million people and discovered that both men and women using these drugs had a 43% greater risk of death. The study highlights the importance of cautious use of these medications, especially among seniors. It's essential for older adults to discuss their medication use with healthcare providers to weigh the benefits and risks.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a systematic review and meta-analysis that examined the link between the use of hypnotics and anxiolytics and increased mortality risk. Researchers reviewed 25 studies involving over 2 million people, finding a 43% higher mortality risk for users of these drugs.
The study analyzed data from various sources, focusing on the risk associated with these medications.
Findings showed increased mortality risk across both genders and among users of benzodiazepines.
There were limitations, such as variations in study designs and populations, which could affect results.
It's crucial for seniors to consult their healthcare providers to understand the risks and benefits of these medications.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Increased Mortality Risk with Hypnotics and Anxiolytics in Older Adults
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 27, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in study design and transparency due to its systematic review and meta-analysis methodology and adherence to PRISMA guidelines. Statistical integrity was strong with appropriate meta-analytic methods. However, bias control was limited by heterogeneity in included studies, and no replication was cited. Relevance was partial due to mixed-age data with subgroup analysis for older adults.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This systematic review and meta-analysis evaluated the mortality risk associated with hypnotics and anxiolytics use, finding a 43% increased risk of mortality among users compared to non-users. The study included 25 studies with over 2 million participants.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.